| Impact of serum storage conditions on microRNA stability S Grasedieck, N Schöler, M Bommer, JH Niess, H Tumani, A Rouhi, ... Leukemia 26 (11), 2414-2416, 2012 | 183 | 2012 |
| The non-coding RNA landscape of human hematopoiesis and leukemia A Schwarzer, S Emmrich, F Schmidt, D Beck, M Ng, C Reimer, FF Adams, ... Nature communications 8 (1), 1-17, 2017 | 159 | 2017 |
| Circulating microRNAs in hematological diseases: principles, challenges, and perspectives S Grasedieck, A Sorrentino, C Langer, C Buske, H Döhner, D Mertens, ... Blood, The Journal of the American Society of Hematology 121 (25), 4977-4984, 2013 | 157 | 2013 |
| Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia S Hirsch, TJ Blätte, S Grasedieck, S Cocciardi, A Rouhi, ... haematologica 102 (12), 2039, 2017 | 77 | 2017 |
| Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia X Niu, K Rothe, M Chen, S Grasedieck, R Li, SE Nam, X Zhang, ... Blood, The Journal of the American Society of Hematology 137 (26), 3641-3655, 2021 | 24 | 2021 |
| Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells A Rouhi, C Miller, S Grasedieck, S Reinhart, B Stolze, H Döhner, ... Oncotarget 8 (5), 7678, 2017 | 19 | 2017 |
| MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells E Schneider, N Pochert, C Ruess, L MacPhee, L Escano, C Miller, ... Leukemia 34 (5), 1253-1265, 2020 | 18 | 2020 |
| Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial R Yen, S Grasedieck, A Wu, H Lin, J Su, K Rothe, H Nakamoto, DL Forrest, ... Leukemia 36 (10), 2443-2452, 2022 | 8 | 2022 |
| Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis A Wu, R Yen, S Grasedieck, H Lin, H Nakamoto, DL Forrest, CJ Eaves, ... Leukemia 37 (12), 2426-2435, 2023 | 7 | 2023 |
| The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements S Grasedieck, A Cabantog, L MacPhee, J Im, C Ruess, B Demir, N Sperb, ... Haematologica 107 (8), 1758, 2022 | 6 | 2022 |
| The non-coding RNA landscape of human hematopoiesis and leukemia. Nat Commun. 2017; 8 A Schwarzer, S Emmrich, F Schmidt, D Beck, M Ng, C Reimer, FF Adams, ... | 6 | 2017 |
| The long non-coding RNA Cancer Susceptibility 15 (CASC15) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia S Grasedieck, C Ruess, K Krowiorz, S Lux, N Pochert, A Schwarzer, ... haematologica 105 (9), e448, 2020 | 4 | 2020 |
| Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier S Grasedieck, A Panahi, MC Jarvis, F Borzooee, RS Harris, M Larijani, ... Leukemia 38 (5), 1172-1177, 2024 | 3 | 2024 |
| Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classes. S Grasedieck, N Sperb, A Rouhi, F Kuchenbauer, D Mertens, M Mulaw, ... Neuropathology & Applied Neurobiology 45 (3), 2019 | 2 | 2019 |
| Identification of novel Lncrnas that predict survival in AML patients and modulate leukemic cells S Grasedieck, C Rueß, N Pochert, S Lux, A Schwarzer, JH Klusmann, ... Blood 132, 3909, 2018 | 2 | 2018 |
| Members of the microRNA-106a-363 cluster associate with unfavorable outcome in adult acute myeloid leukemia patients and promote leukemogenesis in vivo through increased … N Sperb, K Krowiorz, S Grasedieck, C Rueß, N Pochert, E Schneider, ... Blood 132, 3924, 2018 | 2 | 2018 |
| Identification of novel gene fusions in acute myeloid leukemia with complex karyotype by transcriptome analysis using RNA sequencing FG Rücker, X Gong, A Dolnik, M Hoyos, S Grasedieck, J Biscocho, ... Haematologica 102, 39-40, 2017 | 1 | 2017 |
| Identification of Multivariable microRNA and Clinical Biomarkers Panels to Predict Imatinib Response in Chronic Myeloid Leukemia at Diagnosis A Wu, R Yen, S Grasedieck, H Lin, H Nakamoto, DL Forrest, CJ Eaves, ... Blood 142, 4547, 2023 | | 2023 |
| OA-21 Dysregulated APOBEC3B promotes cell proliferation and DNA damage in multiple myeloma A Panahi, S Grasedieck, F Borzooee, M Jarvis, R Harris, M Larijani, ... Clinical Lymphoma Myeloma and Leukemia 23, S13, 2023 | | 2023 |
| Identification of Key microRNAs As Predictive Biomarkers of Nilotinib Response in Chronic Myeloid Leukemia: A Sub-Analysis of the Enestxtnd Clinical Trial A Wu, R Yen, S Grasedieck, H Lin, J Su, K Rothe, H Nakamoto, DL Forrest, ... Blood 140 (Supplement 1), 12169-12170, 2022 | | 2022 |
